Day 2 at OHDSI Rotterdam: Everything You Learned Yesterday Isn't in Your Network Yet

You have been in Rotterdam for 36 hours now. You have heard talks on pharmacovigilance signal synthesis across EMA networks. You have seen poster results from three European cancer registries that share an identical challenge with outcomes they cannot route to each other. You had a hallway conversation with a researcher from a Scandinavian hospital that confirmed what your own institution found six months ago — a drug interaction pattern that never propagated across the OHDSI network because the